Arde Toga Nugraha
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Arde Toga Nugraha has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Chairunnisa
Dept. of Pharmacy, Islamic University of Indonesia, Yogyakarta 55584, Indonesia
1 shared publication - Deni Setiawan
Universitas Lambung Mangkurat
1 shared publication - Fitri Apriliany
Department of Pharmacy, Faculty of Medicine, Bumigora University, Mataram, West Nusa Tenggara, Indonesia
1 shared publication - Hady Anshory Tamhid
Department of Pharmacy, Faculty of Mathematics and Natural Sciences, Universitas Islam Indonesia, Yogyakarta 55584, Indonesia
1 shared publication - Mochammad Saiful Bachri
Department of Pharmacy, Faculty of Pharmacy, Ahmad Dahlan University, Yogyakarta, Indonesia
1 shared publication - Muhammad Ikhwan Rizki
Universitas Lambung Mangkurat
1 shared publication
Latest Publications
- Open Access
- 16 July 2026
- Published by SAGE Publications in Journal of Applied Pharmaceutical Science
Identification of Potential Drug Leads from Dendrobium stuartii Through Integrated In Silico, Phytochemical, and Pharmacological Methods
The genus Dendrobium is a rich source of bioactive secondary metabolites, particularly bibenzyl derivatives with substantial pharmacological activities, but Dendrobium stuartii remains an underexplored species. Therefore, this study aimed to investigate the drug discovery potential of D. stuartii through an integrated in silico and experimental method. Four key compounds were prioritized through literature analysis, and the interactions with the epidermal growth factor receptor (EGFR) were evaluated using molecular docking. The chemical profile of the acetone extract was characterized using Liquid Chromatography–High Resolution Mass Spectrometry (LC-HRMS). Additionally, biological activities were assessed through antibacterial, antibiofilm, and anti-inflammatory assays. Batatasin III had the strongest predicted binding affinity toward EGFR, and the LC-HRMS analysis confirmed the presence of bibenzyl derivative 3,4ʹ-dihydroxy-5,5ʹ-dimethoxybibenzyl (gigantol). The extract provided antibacterial activity, specifically against S. aureus and P. acnes , inhibited biofilm formation during the mid-phase, and produced substantial anti-inflammatory activity, as evidenced by significant inhibition of protein denaturation. The results suggested D. stuartii as a promising underexplored source of bioactive compounds with potential applications in anticancer and anti-infective drug development.
- 16 July 2026
- Published by SAGE Publications in Journal of Applied Pharmaceutical Science
Open AccessIdentification of Potential Drug Leads from Dendrobium stuartii Through Integrated In Silico, Phytochemical, and Pharmacological Methods
The genus Dendrobium is a rich source of bioactive secondary metabolites, particularly bibenzyl derivatives with substantial pharmacological activities, but Dendrobium stuartii remains an underexplored species. Therefore, this study aimed to investigate the drug discovery potential of D. stuartii through an integrated in silico and experimental method. Four key compounds were prioritized through literature analysis, and the interactions with the epidermal growth factor receptor (EGFR) were evaluated using molecular docking. The chemical profile of the acetone extract was characterized using Liquid Chromatography–High Resolution Mass Spectrometry (LC-HRMS). Additionally, biological activities were assessed through antibacterial, antibiofilm, and anti-inflammatory assays. Batatasin III had the strongest predicted binding affinity toward EGFR, and the LC-HRMS analysis confirmed the presence of bibenzyl derivative 3,4ʹ-dihydroxy-5,5ʹ-dimethoxybibenzyl (gigantol). The extract provided antibacterial activity, specifically against S. aureus and P. acnes , inhibited biofilm formation during the mid-phase, and produced substantial anti-inflammatory activity, as evidenced by significant inhibition of protein denaturation. The results suggested D. stuartii as a promising underexplored source of bioactive compounds with potential applications in anticancer and anti-infective drug development.
- 1 January 2017
- Published by AIP Publishing in AIP Conference Proceedings
Gas chromatography – Mass spectrometry analysis and antibacterial activity of Cinnamomum burmanii essential oil to Staphylococcus aureus and Escherichia coli by gaseous contact
Infectious diseases and antibiotic resistance becomes a problem that must be resolved. Plant based products are among the alternative agents examined in order to replace conventional antibiotics. Cinnamaldehyde is one of the compound in cinnamon oil that has antibacterial activity. But the other compounds in cinnamon oil has also the potential antibacterial activity. The purpose of this study to conduct GC-MS analysis of cinnamon oil and its antibacterial activity to Staphylococcus aureus and Escherichia coli by gaseous contact. Cinnamomum burmannii was distilled by water-steam distillation to obtain essential oil. Identification of compounds was analyzed by GC-MS. Antibacterial activity was observed by gaseous contact method in airtight boxes. The GC-MS analyzed showed that there are four major compounds of cinnamon oil, trans-cinnamaldehyde (56,10%), 1,8-cineole (16,53%), α-pinene (3,44%) and α –terpineol (3,05%). The Minimum Inhibitory Dose (MID) of cinnamon oil to E. coli and S. aureus was 12.5 µL/L and 6.26 µL/L respectively. Gas compounds of cinnamon oil has more effective to gram-positive bacteria than gram-negative bacteria.
- 1 January 2017
- Published by AIP Publishing in AIP Conference Proceedings
Gas chromatography – Mass spectrometry analysis and antibacterial activity of Cinnamomum burmanii essential oil to Staphylococcus aureus and Escherichia coli by gaseous contact
Infectious diseases and antibiotic resistance becomes a problem that must be resolved. Plant based products are among the alternative agents examined in order to replace conventional antibiotics. Cinnamaldehyde is one of the compound in cinnamon oil that has antibacterial activity. But the other compounds in cinnamon oil has also the potential antibacterial activity. The purpose of this study to conduct GC-MS analysis of cinnamon oil and its antibacterial activity to Staphylococcus aureus and Escherichia coli by gaseous contact. Cinnamomum burmannii was distilled by water-steam distillation to obtain essential oil. Identification of compounds was analyzed by GC-MS. Antibacterial activity was observed by gaseous contact method in airtight boxes. The GC-MS analyzed showed that there are four major compounds of cinnamon oil, trans-cinnamaldehyde (56,10%), 1,8-cineole (16,53%), α-pinene (3,44%) and α –terpineol (3,05%). The Minimum Inhibitory Dose (MID) of cinnamon oil to E. coli and S. aureus was 12.5 µL/L and 6.26 µL/L respectively. Gas compounds of cinnamon oil has more effective to gram-positive bacteria than gram-negative bacteria.